DarioHealth Corp EBITDA Margin Trend

DRIO -- USA Stock  

USD 1.44  0.04  2.70%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2 M, Gross Profit of 1.3 M or Interest Expense of 2 M, but also many exotic indicators such as Asset Turnover of 0.2659, Current Ratio of 3.7 or Free Cash Flow per Share of 0.43. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed EBITDA Margin of DarioHealth Corp with missing and latest data points interpolated. Measures the ratio between a company's Earnings Before Interest Taxes and Depreciation Amortization EBITDA and Revenues.
EBITDA Margin10 Years Trend
Slightly volatile
 EBITDA Margin 

Regression Statistics

Arithmetic Mean (8.38)
Coefficient Of Variation (4.83)
Mean Deviation  0.21
Median (8.27)
Standard Deviation  0.40
Sample Variance  0.16
Range  1.46
R Value (0.46)
Mean Square Error  0.14
R Squared  0.21
Significance  0.11
Slope (0.048118)
Total Sum of Squares  1.97

DarioHealth Corp EBITDA Margin Over Time

2016-12-31 (8.27) 
2017-12-31 (8.27) 
2018-12-31 (9.73) 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Additionally see analysis of DarioHealth Corp Correlation with competitors. Please also try Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of macroaxis ideas.